US Stock MarketDetailed Quotes

ZVSA ZyVersa Therapeutics

Watchlist

1.1400
-0.0100-0.87%

Close Nov 21 16:00 ET

1.1800
+0.0400+3.51%

Pre 06:11 ET

2.67MMarket Cap-57P/E (TTM)

ZyVersa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 12, 2022

(Q4)Dec 12, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-21.81%2.27M

-46.52%2.75M

-38.45%2.83M

10.82%14.42M

-59.32%1.78M

-14.51%2.9M

173.43%5.15M

36.33%4.59M

68.90%13.01M

145.76%4.37M

Selling and administrative expenses

-17.73%1.83M

-47.96%2.04M

-34.57%2.31M

47.44%11.21M

-50.66%1.52M

110.05%2.23M

237.56%3.93M

53.65%3.54M

36.29%7.61M

169.45%3.08M

-General and administrative expense

-17.73%1.83M

-47.96%2.04M

-34.57%2.31M

47.44%11.21M

-50.66%1.52M

110.05%2.23M

237.56%3.93M

53.65%3.54M

36.29%7.61M

169.45%3.08M

Research and development costs

-35.30%436.04K

-41.91%709.05K

-51.42%512.94K

-40.69%3.21M

-80.03%257.11K

-71.13%673.94K

69.67%1.22M

-1.03%1.06M

154.57%5.41M

103.07%1.29M

Operating profit

21.81%-2.27M

46.52%-2.75M

38.45%-2.83M

-10.82%-14.42M

59.32%-1.78M

14.51%-2.9M

-173.43%-5.15M

-36.33%-4.59M

-68.90%-13.01M

-145.76%-4.37M

Net non-operating interest income expense

-62,583.33%-131.64K

81.53%-58

-109.37%-101

100.11%457

99.80%-98

99.70%-210

99.78%-314

100.64%1.08K

47.95%-427.54K

75.71%-49.72K

Non-operating interest income

----

--457

---98

----

--1.08K

----

Non-operating interest expense

62,583.33%131.64K

----

--101

----

-99.70%210

----

-47.95%427.54K

-75.71%49.72K

Total other finance cost

----

-81.53%58

----

-99.78%314

----

Other net income (expense)

-15,276.16%-93.33M

-6,422.63%-12.16M

-414,259.20%-81.18M

-237.46%-607K

-1,627.88%-186.4K

Gain on sale of security

----

-366.11%-607K

-1,627.88%-186.4K

Special income (charges)

--0

----

---93.33M

---12.16M

--0

---81.18M

----

--0

-Less:Impairment of capital assets

--0

----

--11.9M

--0

--11.9M

----

--0

-Write off

--0

----

--81.44M

--12.16M

--0

--69.28M

----

--0

Income before tax

17.28%-2.4M

96.81%-2.75M

38.43%-2.83M

-667.06%-107.75M

-202.78%-13.93M

21.39%-2.9M

-4,207.19%-86.33M

-22.48%-4.59M

-73.77%-14.05M

-133.72%-4.6M

Income tax

100.12%9.71K

-9.46M

-596.07K

-485

-7.81M

-1.05M

Net income

17.27%-2.4M

96.48%-2.76M

20.24%-2.83M

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

Net income continuous Operations

17.27%-2.4M

96.48%-2.76M

20.24%-2.83M

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

Minority interest income

Net income attributable to the parent company

17.27%-2.4M

96.48%-2.76M

20.24%-2.83M

-599.75%-98.3M

-189.82%-13.34M

21.40%-2.9M

-3,817.40%-78.51M

5.46%-3.54M

-73.77%-14.05M

-133.72%-4.6M

Preferred stock dividends

-20.64%7.95M

-99.67%32.37K

2,290.05%7.92M

10.02M

Other preferred stock dividends

Net income attributable to common stockholders

18.18%-2.4M

96.80%-2.76M

20.24%-2.83M

-341.53%-106.25M

-189.82%-13.34M

78.06%-2.93M

-3,600.80%-86.43M

5.46%-3.54M

-197.66%-24.06M

-133.72%-4.6M

Basic earnings per share

91.95%-2.43

98.05%-33.1

96.67%-45.3

-214.85%-1.09K

81.44%-32.9179

94.15%-30.18

-4,740.34%-1.69K

-2,408.63%-1.36K

-147.42%-346.104

-523.36%-177.3656

Diluted earnings per share

91.95%-2.43

98.05%-33.1

96.67%-45.3

-214.85%-1.09K

81.44%-32.9179

94.15%-30.18

-4,740.34%-1.69K

-2,408.63%-1.36K

-147.42%-346.104

-523.36%-177.3656

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 12, 2022	(Q4)Dec 12, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-21.81%2.27M	-46.52%2.75M	-38.45%2.83M	10.82%14.42M	-59.32%1.78M	-14.51%2.9M	173.43%5.15M	36.33%4.59M	68.90%13.01M	145.76%4.37M
Selling and administrative expenses	-17.73%1.83M	-47.96%2.04M	-34.57%2.31M	47.44%11.21M	-50.66%1.52M	110.05%2.23M	237.56%3.93M	53.65%3.54M	36.29%7.61M	169.45%3.08M
-General and administrative expense	-17.73%1.83M	-47.96%2.04M	-34.57%2.31M	47.44%11.21M	-50.66%1.52M	110.05%2.23M	237.56%3.93M	53.65%3.54M	36.29%7.61M	169.45%3.08M
Research and development costs	-35.30%436.04K	-41.91%709.05K	-51.42%512.94K	-40.69%3.21M	-80.03%257.11K	-71.13%673.94K	69.67%1.22M	-1.03%1.06M	154.57%5.41M	103.07%1.29M
Operating profit	21.81%-2.27M	46.52%-2.75M	38.45%-2.83M	-10.82%-14.42M	59.32%-1.78M	14.51%-2.9M	-173.43%-5.15M	-36.33%-4.59M	-68.90%-13.01M	-145.76%-4.37M
Net non-operating interest income expense	-62,583.33%-131.64K	81.53%-58	-109.37%-101	100.11%457	99.80%-98	99.70%-210	99.78%-314	100.64%1.08K	47.95%-427.54K	75.71%-49.72K
Non-operating interest income	----	----	----	--457	---98	----	----	--1.08K	----	----
Non-operating interest expense	62,583.33%131.64K	----	--101	----	----	-99.70%210	----	----	-47.95%427.54K	-75.71%49.72K
Total other finance cost	----	-81.53%58	----	----	----	----	-99.78%314	----	----	----
Other net income (expense)				-15,276.16%-93.33M	-6,422.63%-12.16M		-414,259.20%-81.18M		-237.46%-607K	-1,627.88%-186.4K
Gain on sale of security	----	----	----	----	----	----	----	----	-366.11%-607K	-1,627.88%-186.4K
Special income (charges)	--0	--0	----	---93.33M	---12.16M	--0	---81.18M	----	--0	--0
-Less:Impairment of capital assets	--0	--0	----	--11.9M	--0	--0	--11.9M	----	--0	--0
-Write off	--0	--0	----	--81.44M	--12.16M	--0	--69.28M	----	--0	--0
Income before tax	17.28%-2.4M	96.81%-2.75M	38.43%-2.83M	-667.06%-107.75M	-202.78%-13.93M	21.39%-2.9M	-4,207.19%-86.33M	-22.48%-4.59M	-73.77%-14.05M	-133.72%-4.6M
Income tax	0	100.12%9.71K	0	-9.46M	-596.07K	-485	-7.81M	-1.05M	0	0
Net income	17.27%-2.4M	96.48%-2.76M	20.24%-2.83M	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M
Net income continuous Operations	17.27%-2.4M	96.48%-2.76M	20.24%-2.83M	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M
Minority interest income
Net income attributable to the parent company	17.27%-2.4M	96.48%-2.76M	20.24%-2.83M	-599.75%-98.3M	-189.82%-13.34M	21.40%-2.9M	-3,817.40%-78.51M	5.46%-3.54M	-73.77%-14.05M	-133.72%-4.6M
Preferred stock dividends				-20.64%7.95M	0	-99.67%32.37K	2,290.05%7.92M		10.02M	0
Other preferred stock dividends
Net income attributable to common stockholders	18.18%-2.4M	96.80%-2.76M	20.24%-2.83M	-341.53%-106.25M	-189.82%-13.34M	78.06%-2.93M	-3,600.80%-86.43M	5.46%-3.54M	-197.66%-24.06M	-133.72%-4.6M
Basic earnings per share	91.95%-2.43	98.05%-33.1	96.67%-45.3	-214.85%-1.09K	81.44%-32.9179	94.15%-30.18	-4,740.34%-1.69K	-2,408.63%-1.36K	-147.42%-346.104	-523.36%-177.3656
Diluted earnings per share	91.95%-2.43	98.05%-33.1	96.67%-45.3	-214.85%-1.09K	81.44%-32.9179	94.15%-30.18	-4,740.34%-1.69K	-2,408.63%-1.36K	-147.42%-346.104	-523.36%-177.3656
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data